This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Grundy SM et al. (2004) Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. J Am Coll Cardiol 44: 720–732
Foley KA et al. (2004) Effectiveness of statin titration on Low-Density lipoprotein cholesterol goal attainment in patients at high risk of atherogenic events. Am J Cardiol 92: 79–81
Pasternak RC et al. (2002) ACC/AHA/NHLBI Clinical advisory on the use and safety of statins. J Am Coll Cardiol 40: 567–572
Gaist D et al. (2001) Lipid-lowering drugs and risk of myopathy: a population-based follow-up study. Epidemiology 12: 565–569
Phillips PS et al. and the Scripps Mercy Clinical Research Center (2004) Statin Myotoxicity is Associated with Changes in the Respiratory Exchange Ratio. Atherosclerosis 177: 183–188
Kordas KC et al. (2004) Clinical characteristics of 1053 patients with statin associated muscle complaints [abstract]. Arterioscler Thromb Vasc Biol 24: e51–e136
Acknowledgements
The synopsis was written by Hannah Camm, Associate Editor, Nature Clinical Practice.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Phillips, P. How common is rhabdomyolysis in patients receiving lipid-lowering therapy?. Nat Rev Cardiol 2, 130–131 (2005). https://doi.org/10.1038/ncpcardio0125
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/ncpcardio0125